Comment
doi: 10.1016/S0140-6736(20)30527-4.
Epub 2020 Mar 22.
Prostate-specific membrane antigen PET-CT before radical treatment
Affiliations
- PMID: 32209450
- DOI: 10.1016/S0140-6736(20)30527-4
Item in Clipboard
Comment
Prostate-specific membrane antigen PET-CT before radical treatment
Lancet.
.
No abstract available
Comment on
-
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.Lancet. 2020 Apr 11;395(10231):1208-1216. doi: 10.1016/S0140-6736(20)30314-7. Epub 2020 Mar 22. Lancet. 2020. PMID: 32209449 Clinical Trial.
Similar articles
-
Efficacy, Predictive Factors, and Prediction Nomograms for 68Ga-labeled Prostate-specific Membrane Antigen-ligand Positron-emission Tomography/Computed Tomography in Early Biochemical Recurrent Prostate Cancer After Radical Prostatectomy.Eur Urol. 2018 May;73(5):656-661. doi: 10.1016/j.eururo.2018.01.006. Epub 2018 Jan 19. Eur Urol. 2018. PMID: 29358059
-
Gallium-68-prostate-specific membrane antigen (68 Ga-PSMA) positron emission tomography (PET)/computed tomography (CT) predicts complete biochemical response from radical prostatectomy and lymph node dissection in intermediate- and high-risk prostate cancer.BJU Int. 2019 Jul;124(1):62-68. doi: 10.1111/bju.14506. Epub 2019 Apr 7. BJU Int. 2019. PMID: 30074667
-
Clinical Relevance of Incidental Prostatic Lesions on FDG-Positron Emission Tomography/Computerized Tomography-Should Patients Receive Further Evaluation?J Urol. 2016 Apr;195(4 Pt 1):907-12. doi: 10.1016/j.juro.2015.11.025. Epub 2015 Nov 17. J Urol. 2016. PMID: 26598424
-
New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.Eur Urol. 2016 Jul;70(1):161-175. doi: 10.1016/j.eururo.2016.01.029. Epub 2016 Feb 2. Eur Urol. 2016. PMID: 26850970 Review.
-
[The role of PSMA PET-CT in patients with metastatic prostate cancer].Radiologe. 2018 Mar;58(3):226-232. doi: 10.1007/s00117-018-0358-8. Radiologe. 2018. PMID: 29344704 Review. German.
Cited by
-
Preoperative evaluation of prostate cancer by 68Ga-PMSA positron emission tomography/computed tomography: comparison with magnetic resonance imaging and with histopathological findings.Radiol Bras. 2023 Jul-Aug;56(4):171-178. doi: 10.1590/0100-3984.2022.0122-en. Radiol Bras. 2023. PMID: 37829589 Free PMC article.
-
Circular RNA circARHGEF28 inhibited the progression of prostate cancer via the miR-671-5p/LGALS3BP/NF-κB axis.Cancer Sci. 2023 Jul;114(7):2907-2919. doi: 10.1111/cas.15820. Epub 2023 Apr 26. Cancer Sci. 2023. PMID: 37186007 Free PMC article.
-
Construction and validation of a fatty acid metabolism-related gene signature for predicting prognosis and therapeutic response in patients with prostate cancer.PeerJ. 2023 Feb 6;11:e14854. doi: 10.7717/peerj.14854. eCollection 2023. PeerJ. 2023. PMID: 36778142 Free PMC article.
-
A Novel Risk Factor Model Based on Glycolysis-Associated Genes for Predicting the Prognosis of Patients With Prostate Cancer.Front Oncol. 2021 Sep 14;11:605810. doi: 10.3389/fonc.2021.605810. eCollection 2021. Front Oncol. 2021. PMID: 34595101 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
